As the number of drug-related overdoses in public spaces continues to rise, physicians such as Jessie Gaeta are treating patients far outside the traditional exam room—including in bathrooms and on the streets.

Committees in the Senate and House on Tuesday began a series of hearings focused on health care issues, including prescription drug prices, protections for U.S. residents with pre-existing medical conditions, and health insurance options.

Technology companies at this year's Consumer Electronic Show unveiled various personal health care devices that aim to address common—and not-so-common—health concerns.

A federal prosecutor on Monday accused former Insys Therapeutics CEO John Kapoor and four of the company's other executives of contributing to the U.S. opioid epidemic by using illegal marketing tactics to drive up sales of the opioid drug Subsys—but Beth Wilkinson, a lawyer representing Kapoor, says the charges are "patently false."

FDA on Friday announced that it has identified the source of impurities believed to cause cancer that prompted recalls of various generic blood pressure and heart failure medications.

President Trump on Friday signed into law a bill that temporarily funds FDA, the Indian Health Service, and other federal agencies that were affected by the partial government shutdown that lasted a record 35 days—but experts say it is unclear how FDA will resume its operations and bring back furloughed staff.

New research suggests the Trump administration's proposal to require drugmakers to include prices in television advertisements for their products could have an effect on how consumers view the products.

Civica Rx, a health system-led nonprofit that intends to address rising prescription drug prices and shortages, said it expects it will be able to supply a total of about 20 different drug products in 2019.

The World Health Organization breaks down the 10 biggest threats to global health in 2019. See what made the list.

Per-person spending on insulin for patients with Type 1 diabetes nearly doubled from 2012 to 2016, driven in large part by rising insulin prices, according to a recent Health Care Cost Institute report.